Pedro Bastos-Mendes

Lisbon, 1998018, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications

Correction: Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Correction: Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Journal: Dermatology and therapy
Published: August 11, 2026

Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

Journal: Clinical reviews in allergy & immunology
Published: August 04, 2026

Complete clearance of high-impact sites with risankizumab in patients with psoriasis: a 2-year real-world retrospective multicenter cohort study.

Complete clearance of high-impact sites with risankizumab in patients with psoriasis: a 2-year real-world retrospective multicenter cohort study.

Journal: The Journal of dermatological treatment
Published: May 06, 2026

The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

Journal: Clinical reviews in allergy & immunology
Published: April 16, 2026

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Journal: Dermatology and therapy
Published: March 06, 2026

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.

Journal: Dermatology and therapy
Published: March 03, 2026

Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region.

Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region.

Journal: Dermatology and therapy
Published: February 23, 2026

Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort.

Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort.

Journal: The Journal of dermatological treatment
Published: January 23, 2026

Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).

Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).

Journal: Dermatology and therapy
Published: December 19, 2025

Real-World Evidence on Dose Spacing of Risankizumab for Psoriasis: A Multicenter Retrospective Cohort Study.

Real-World Evidence on Dose Spacing of Risankizumab for Psoriasis: A Multicenter Retrospective Cohort Study.

Journal: Dermatology and therapy
Published: October 07, 2025

Risankizumab in Patients with Psoriasis with Current or Previous Malignancy: A Multicenter, Retrospective Real-World Study.

Risankizumab in Patients with Psoriasis with Current or Previous Malignancy: A Multicenter, Retrospective Real-World Study.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: September 17, 2025

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease.

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease.

Journal: Movement disorders clinical practice
Published: August 05, 2025
Showing 1-12 of 84

Last Updated: 09/26/2026